Matrix metalloproteinases in stem cell mobilization

Matrix Biology

Volumn 44-46, Issue , 2015, Pages 175-183

  Klein, Gerd ^a   Schmal, Olga ^a   Aicher, Wilhelm K ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Extracellular matrix; Hematopoietic stem cells; Proteolytic microenvironment; Stem cell homing; Stem cell niche

Indexed keywords

ANTIINFECTIVE AGENT; CHEMOKINE; CYTOKINE; GROWTH FACTOR; MATRIX METALLOPROTEINASE; SCLEROPROTEIN;

CELL HOMING; ENGRAFTMENT; EXTRACELLULAR MATRIX; HEMATOPOIETIC STEM CELL; HUMAN; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; STEM CELL MOBILIZATION; STEM CELL NICHE; ANIMAL; CYTOLOGY; METABOLISM; PHYSIOLOGY;

ANIMALS; CYTOKINES; EXTRACELLULAR MATRIX PROTEINS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; MATRIX METALLOPROTEINASES; STEM CELL NICHE;

EID: 84930753334     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2015.01.011     Document Type: Review

References (78)

1. Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 1978, 4:7-25.
2. Calvi L.M., Adams G.B., Weibrecht K.W., Weber J.M., Olson D.P., Knight M.C., et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003, 425:841-846.
3. Zhang J., Niu C., Ye L., Huang H., He X., Tong W.-G., et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003, 425:836-841.
4. Ehninger A., Trumpp A. The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J Exp Med 2011, 208:421-428.
5. Bianco P. Bone and the hematopoietic niche: a tale of two stem cells. Blood 2011, 117:5281-5288.
6. Morrison S.J., Scadden D.T. The bone marrow niche for haematopoietic stem cells. Nature 2014, 505:327-334.
7. Chow A., Lucas D., Hidalgo A., Mendez-Ferrer S., Hashimoto D., Scheiermann C., et al. Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J Exp Med 2011, 208:261-271.
8. Winkler I.G., Sims N.A., Pettit A.R., Barbier V., Nowlan B., Helwani F., et al. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood 2010, 116:4815-4828.
9. Chan C.K., Chen C.C., Luppen C.A., Kim J.B., DeBoer A.T., Wei K., et al. Endochondral ossification is required for haematopoietic stem-cell niche formation. Nature 2009, 457:490-494.
10. Sacchetti B., Funari A., Michienzi S., Di Cesare S., Piersanti S., Saggio I., et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007, 131:324-336.
11. Kollet O., Dar A., Shivtiel S., Kalinkovich A., Lapid K., Sztainberg Y., et al. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med 2006, 12:657-664.
12. Mendez-Ferrer S., Michurina T.V., Ferraro F., Mazloom A.R., Macarthur B.D., Lira S.A., et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466:829-834.
13. Ding L., Saunders T.L., Enikolopov G., Morrison S.J. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 2012, 481:457-462.
14. Sugiyama T., Kohara H., Noda M., Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006, 25:977-988.
15. Hanoun M., Frenette P.S. This niche is a maze; an amazing niche. Cell Stem Cell 2013, 12:391-392.
16. Mendez-Ferrer S., Lucas D., Battista M., Frenette P.S. Haematopoietic stem cell release is regulated by circadian oscillations. Nature 2008, 452:442-447.
17. Katayama Y., Battista M., Kao W.M., Hidalgo A., Peired A.J., Thomas S.A., et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 2006, 124:407-421.
18. Naveiras O., Nardi V., Wenzel P.L., Hauschka P.V., Fahey F., Daley G.Q. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature 2009, 460:259-263.
19. Greenbaum A., Hsu Y.M., Day R.B., Schuettpelz L.G., Christopher M.J., Borgerding J.N., et al. CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature 2013, 495:227-230.
20. Tzeng Y.S., Li H., Kang Y.L., Chen W.C., Cheng W.C., Lai D.M. Loss of Cxcl12/Sdf-1 in adult mice decreases the quiescent state of hematopoietic stem/progenitor cells and alters the pattern of hematopoietic regeneration after myelosuppression. Blood 2011, 117:429-439.
21. Mendelson A., Frenette P.S. Hematopoietic stem cell niche maintenance during homeostasis and regeneration. Nat Med 2014, 20:833-846.
22. Winkler I.G., Barbier V., Nowlan B., Jacobsen R.N., Forristal C.E., Patton J.T., et al. Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance. Nat Med 2012, 18:1651-1657.
23. Liu Y., Chen X.H., Si Y.J., Li Z.J., Gao L., Zhang C., et al. Reconstruction of hematopoietic inductive microenvironment after transplantation of VCAM-1-modified human umbilical cord blood stromal cells. PLoS One 2012, 7:e31741.
24. Avigdor A., Goichberg P., Shivtiel S., Dar A., Peled A., Samira S., et al. CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood 2004, 103:2981-2989.
25. Lee S., Im S.A., Yoo E.S., Nam E.M., Lee M.A., Ahn J.Y., et al. Mobilization kinetics of CD34(+) cells in association with modulation of CD44 and CD31 expression during continuous intravenous administration of G-CSF in normal donors. Stem Cells 2000, 18:281-286.
26. Holst J., Watson S., Lord M.S., Eamegdool S.S., Bax D.V., Nivison-Smith L.B., et al. Substrate elasticity provides mechanical signals for the expansion of hemopoietic stem and progenitor cells. Nat Biotechnol 2010, 28:1123-1128.
27. Lee-Thedieck C., Rauch N., Fiammengo R., Klein G., Spatz J.P. Impact of substrate elasticity on human hematopoietic stem and progenitor cell adhesion and motility. J Cell Sci 2012, 125:3765-3775.
28. Shin J.W., Buxboim A., Spinler K.R., Swift J., Christian D.A., Hunter C.A., et al. Contractile forces sustain and polarize hematopoiesis from stem and progenitor cells. Cell Stem Cell 2014, 14:81-93.
29. Kilian K.A., Bugarija B., Lahn B.T., Mrksich M. Geometric cues for directing the differentiation of mesenchymal stem cells. Proc Natl Acad Sci U S A 2010, 107:4872-4877.
30. Adams G.B., Chabner K.T., Alley I.R., Olson D.P., Szczepiorkowski Z.M., Poznansky M.C., et al. Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature 2006, 439:599-603.
31. Klein G., Kibler C., Schermutzki F., Brown J., Müller C.A., Timpl R. Cell binding properties of collagen type XIV for human hematopoietic cells. Matrix Biol 1998, 16:307-317.
32. Klein G., Müller C.A., Tillet E., Chu M.L., Timpl R. Collagen type VI in the human bone marrow microenvironment: a strong cytoadhesive component. Blood 1995, 86:1740-1748.
33. Ekblom M., Fässler R., Tomasini-Johansson B., Nilsson K., Ekblom P. Downregulation of tenascin expression by glucocorticoids in bone marrow stromal cells and in fibroblasts. J Cell Biol 1993, 123:1037-1045.
34. Klein G., Beck S., Müller C.A. Tenascin is a cytoadhesive extracellular matrix component of the human hematopoietic microenvironment. J Cell Biol 1993, 123:1027-1035.
35. Seiffert M., Beck S.C., Schermutzki F., Müller C.A., Erickson H.P., Klein G. Mitogenic and adhesive effects of tenascin-C on human hematopoietic cells are mediated by various functional domains. Matrix Biol 1998, 17:47-63.
36. Ohta M., Sakai T., Saga Y., Aizawa S.-i., Saito M. Suppression of hematopoietic activity in tenascin-C-deficient mice. Blood 1998, 91:4074-4083.
37. Nakamura-Ishizu A., Okuno Y., Omatsu Y., Okabe K., Morimoto J., Uede T., et al. Extracellular matrix protein tenascin-C is required in the bone marrow microenvironment primed for hematopoietic regeneration. Blood 2012, 119:5429-5437.
38. Schreiber T.D., Steinl C., Essl M., Abele H., Geiger K., Müller C.A., et al. The integrin alpha9beta1 on hematopoietic stem and progenitor cells: involvement in cell adhesion, proliferation and differentiation. Haematologica 2009, 94:1493-1501.
39. Stier S., Ko Y., Forkert R., Lutz C., Neuhaus T., Grunewald E., et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J Exp Med 2005, 201:1781-1791.
40. Nilsson S.K., Johnston H.M., Whitty G.A., Williams B., Webb R.J., Denhardt D.T., et al. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 2005, 106:1232-1239.
41. Grassinger J., Haylock D.N., Storan M.J., Haines G.O., Williams B., Whitty G.A., et al. Thrombin-cleaved osteopontin regulates hemopoietic stem and progenitor cell functions through interactions with alpha9beta1 and alpha4beta1 integrins. Blood 2009, 114:49-59.
42. Hergeth S.P., Aicher W.K., Essl M., Schreiber T.D., Sasaki T., Klein G. Characterization and functional analysis of osteoblast-derived fibulins in the human hematopoietic stem cell niche. Exp Hematol 2008, 36:1022-1034.
43. Klein G., Conzelmann S., Beck S., Timpl R., Müller C.A. Perlecan in human bone marrow: a growth-factor-presenting, but anti-adhesive, extracellular matrix component for hematopoietic cells. Matrix Biol 1995, 14:457-465.
44. Mazzon C., Anselmo A., Cibella J., Soldani C., Destro A., Kim N., et al. The critical role of agrin in the hematopoietic stem cell niche. Blood 2011, 118:2733-2742.
45. Gu Y., Sorokin L., Durbeej M., Hjalt T., Jonsson J.-I., Ekblom M. Characterization of bone marrow laminins and identification of alpha 5-containing laminins as adhesive proteins for multipotent hematopoietic FDCP-mix cells. Blood 1999, 93:2533-2542.
46. Gu Y.-C., Kortesmaa J., Tryggvason K., Persson J., Ekblom P., Jacobsen S.-E., et al. Laminin isoform-specific promotion of adhesion and migration of human bone marrow progenitor cells. Blood 2003, 101:877-885.
47. Siler U., Seiffert M., Puch S., Richards A., Torok-Storb B., Müller C.A., et al. Characterization and functional analysis of laminin isoforms in human bone marrow. Blood 2000, 96:4194-4203.
48. Bendall L.J., Bradstock K.F. G-CSF: from granulopoietic stimulant to bone marrow stem cell mobilizing agent. Cytokine Growth Factor Rev 2014, 25:355-367.
49. Lapidot T., Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 2002, 30:973-981.
50. Greenbaum A.M., Link D.C. Mechanisms of G-CSF-mediated hematopoietic stem and progenitor mobilization. Leukemia 2011, 25:211-217.
51. Levesque J.-P., Hendy J., Takamatsu Y., Williams B., Winkler I.G., Simmons P.J. Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. Exp Hematol 2002, 30:440-449.
52. Marquez-Curtis L., Jalili A., Deiteren K., Shirvaikar N., Lambeir A.M., Janowska-Wieczorek A. Carboxypeptidase M expressed by human bone marrow cells cleaves the C-terminal lysine of stromal cell-derived factor-1alpha: another player in hematopoietic stem/progenitor cell mobilization?. Stem Cells 2008, 26:1211-1220.
53. Staudt N.D., Aicher W.K., Kalbacher H., Stevanovic S., Carmona A.K., Bogyo M., et al. Cathepsin X is secreted by human osteoblasts, digests CXCL-12 and impairs adhesion of hematopoietic stem and progenitor cells to osteoblasts. Haematologica 2010, 95:1452-1460.
54. Christopherson K.W., Cooper S., Hangoc G., Broxmeyer H.E. CD26 is essential for normal G-CSF-induced progenitor cell mobilization as determined by CD26-/-mice. Exp Hematol 2003, 31:1126-1134.
55. Winkler I.G., Hendy J., Coughlin P., Horvath A., Levesque J.P. Serine protease inhibitors serpina1 and serpina3 are down-regulated in bone marrow during hematopoietic progenitor mobilization. J Exp Med 2005, 201:1077-1088.
56. van Pel M., van Os R., Velders G.A., Hagoort H., Heegaard P.M., Lindley I.J., et al. Serpina1 is a potent inhibitor of IL-8-induced hematopoietic stem cell mobilization. Proc Natl Acad Sci U S A 2006, 103:1469-1474.
57. Heissig B., Hattori K., Dias S., Friedrich M., Ferris B., Hackett N.R., et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand. Cell 2002, 109:625-637.
58. Levesque J.P., Hendy J., Winkler I.G., Takamatsu Y., Simmons P.J. Granulocyte colony-stimulating factor induces the release in the bone marrow of proteases that cleave c-KIT receptor (CD117) from the surface of hematopoietic progenitor cells. Exp Hematol 2003, 31:109-117.
59. Levesque J.P., Hendy J., Takamatsu Y., Simmons P.J., Bendall L.J. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 2003, 111:187-196.
60. McQuibban G.A., Butler G.S., Gong J.H., Bendall L., Power C., Clark-Lewis I., et al. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 2001, 276:43503-43508.
61. Steinl C., Essl M., Schreiber T.D., Geiger K., Prokop L., Stevanovic S., et al. Release of matrix metalloproteinase-8 during physiological trafficking and induced mobilization of human hematopoietic stem cells. Stem Cells Dev 2013, 22:1307-1318.
62. Janowski M. Functional diversity of SDF-1 splicing variants. Cell Adh Migr 2009, 3:243-249.
63. Levesque J.P., Takamatsu Y., Nilsson S.K., Haylock D.N., Simmons P.J. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 2001, 98:1289-1297.
64. Patterson M.L., Atkinson S.J., Knauper V., Murphy G. Specific collagenolysis by gelatinase A, MMP-2, is determined by the hemopexin domain and not the fibronectin-like domain. FEBS Lett 2001, 503:158-162.
65. Janowska-Wieczorek A., Marquez L.A., Matsuzaki A., Hashmi H.R., Larratt L.M., Boshkov L.M., et al. Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells. Br J Haematol 1999, 105:402-411.
66. Pruijt J.F.M., Fibbe W.E., Laterveer L., Pieters R.A., Lindley I.J.D., Paemen L., et al. Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9). Proc Natl Acad Sci U S A 1999, 96:10863-10868.
67. Robinson S.N., Pisarev V.M., Chavez J.M., Singh R.K., Talmadge J.E. Use of matrix metalloproteinase (MMP)-9 knockout mice demonstrates that MMP-9 activity is not absolutely required for G-CSF or Flt-3 ligand-induced hematopoietic progenitor cell mobilization or engraftment. Stem Cells 2003, 21:417-427.
68. Levesque J.P., Liu F., Simmons P.J., Betsuyaku T., Senior R.M., Pham C., et al. Characterization of hematopoietic progenitor mobilization in protease-deficient mice. Blood 2004, 104:65-72.
69. Ponte A.L., Ribeiro-Fleury T., Chabot V., Gouilleux F., Langonne A., Herault O., et al. Granulocyte-colony-stimulating factor stimulation of bone marrow mesenchymal stromal cells promotes CD34+ cell migration via a matrix metalloproteinase-2-dependent mechanism. Stem Cells Dev 2012, 21:3162-3172.
70. Overall C.M. Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites. Mol Biotechnol 2002, 22:51-86.
71. Itoh Y., Seiki M. MT1-MMP: a potent modifier of pericellular microenvironment. J Cell Physiol 2006, 206:1-8.
72. Endo K., Takino T., Miyamori H., Kinsen H., Yoshizaki T., Furukawa M., et al. Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. J Biol Chem 2003, 278:40764-40770.
73. Vagima Y., Avigdor A., Goichberg P., Shivtiel S., Tesio M., Kalinkovich A., et al. MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilization. J Clin Invest 2009, 119:492-503.
74. Shirvaikar N., Marquez-Curtis L.A., Shaw A.R., Turner A.R., Janowska-Wieczorek A. MT1-MMP association with membrane lipid rafts facilitates G-CSF-induced hematopoietic stem/progenitor cell mobilization. Exp Hematol 2010, 38:823-835.
75. Zitka O., Kukacka J., Krizkova S., Huska D., Adam V., Masarik M., et al. Matrix metalloproteinases. Curr Med Chem 2010, 17:3751-3768.
76. Oh J., Takahashi R., Kondo S., Mizoguchi A., Adachi E., Sasahara R.M., et al. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 2001, 107:789-800.
77. Vestweber D., Wessel F., Nottebaum A.F. Similarities and differences in the regulation of leukocyte extravasation and vascular permeability. Semin Immunopathol 2014, 36:177-192.
78. Zheng Y., Watanabe N., Nagamura-Inoue T., Igura K., Nagayama H., Tojo A., et al. Ex vivo manipulation of umbilical cord blood-derived hematopoietic stem/progenitor cells with recombinant human stem cell factor can up-regulate levels of homing-essential molecules to increase their transmigratory potential. Exp Hematol 2003, 31:1237-1246.